CA2306812A1 - Ail de qualite pharmaceutique - Google Patents

Ail de qualite pharmaceutique Download PDF

Info

Publication number
CA2306812A1
CA2306812A1 CA002306812A CA2306812A CA2306812A1 CA 2306812 A1 CA2306812 A1 CA 2306812A1 CA 002306812 A CA002306812 A CA 002306812A CA 2306812 A CA2306812 A CA 2306812A CA 2306812 A1 CA2306812 A1 CA 2306812A1
Authority
CA
Canada
Prior art keywords
garlic
bioactivity
pharmaceutical grade
fingerprint
botanical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002306812A
Other languages
English (en)
Inventor
Tasneem A. Khwaja
Elliot P. Friedman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PharmaPrint Inc
University of Southern California USC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2306812A1 publication Critical patent/CA2306812A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Analytical Chemistry (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La présente invention a trait de manière générale à des matières d'ail et à des procédés de transformation de ces matières en formes utiles d'un point de vue médicinal et pharmaceutiquement acceptables. Plus particulièrement, l'invention a trait à l'utilisation d'empreintes de composition et d'activité dans le traitement de matières d'ail pour produire des médicaments qui remplissent les conditions requises pour constituer des compositions de qualité pharmaceutique convenant pour un usage clinique ou vétérinaire en vue de traiter et/ou soulager des maladies, des affections ou des états pathologiques.
CA002306812A 1997-10-23 1998-10-23 Ail de qualite pharmaceutique Abandoned CA2306812A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95671897A 1997-10-23 1997-10-23
US08/956,718 1997-10-23
PCT/US1998/022508 WO1999021008A1 (fr) 1997-10-23 1998-10-23 Ail de qualite pharmaceutique

Publications (1)

Publication Number Publication Date
CA2306812A1 true CA2306812A1 (fr) 1999-04-29

Family

ID=25498602

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002306812A Abandoned CA2306812A1 (fr) 1997-10-23 1998-10-23 Ail de qualite pharmaceutique

Country Status (3)

Country Link
AU (1) AU1118299A (fr)
CA (1) CA2306812A1 (fr)
WO (1) WO1999021008A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3085948B1 (ja) * 1999-05-10 2000-09-11 株式会社東京精密 ウェーハ研磨装置
GB0120887D0 (en) * 2001-08-29 2001-10-17 Sahajanand Biotech Private Ltd Local drug delivery system in coronary stents
AU2005216970B2 (en) * 2004-02-23 2011-07-07 Trustees Of Tufts College Inhibitors of dipeptidylpeptidase IV for regulating glucose metabolism
CN101565429A (zh) * 2004-02-23 2009-10-28 塔夫茨大学信托人 调节葡萄糖代谢的二肽基肽酶ⅳ抑制剂
AU2011203039B2 (en) * 2004-02-23 2013-02-21 Trustees Of Tufts College Inhibitors of dipeptidylpeptidase IV for regulating glucose metabolism
CA2833703A1 (fr) 2004-05-05 2005-11-17 Voloagri Group, Inc. Ail vert et procedes de production
ES2571998T3 (es) * 2010-12-08 2016-05-27 Univ Danmarks Tekniske Composiciones y usos médicos de derivados del ajoeno
WO2014101051A1 (fr) 2012-12-27 2014-07-03 Kimberly-Clark Worldwide, Inc. Analogues de farnésol solubles dans l'eau et leur utilisation
GB2524207B (en) 2012-12-27 2020-07-29 Kimberly Clark Co Water soluble essential oils and their use
US11167002B2 (en) * 2019-08-26 2021-11-09 David Xiage Gan Pharmaceutical composition for the treatment of malignant neoplasms including sarcoma, cancers of liver, lung, bladder, blood and cervical, treatment of infectious diseases and type 2 diabetes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6379714B1 (en) * 1995-04-14 2002-04-30 Pharmaprint, Inc. Pharmaceutical grade botanical drugs
EP0824355A4 (fr) * 1995-04-14 1998-12-30 Univ Southern California Extrait de gui et compose correspondant

Also Published As

Publication number Publication date
AU1118299A (en) 1999-05-10
WO1999021008A1 (fr) 1999-04-29

Similar Documents

Publication Publication Date Title
Saggu et al. Adaptogenic and safety evaluation of seabuckthorn (Hippophae rhamnoides) leaf extract: a dose dependent study
US6039950A (en) Pharmaceutical grade saw palmetto
US6113907A (en) Pharmaceutical grade St. John's Wort
Goulart et al. Anti-inflammatory evaluation of Solidago chilensis Meyen in a murine model of pleurisy
CA2307614A1 (fr) Echinacee de qualite pharmaceutique
CA2306812A1 (fr) Ail de qualite pharmaceutique
Bouimeja et al. Studies on antivenom activity of Lactuca serriola methanolic extract against Buthus atlantis scorpion venom by in vivo methods
Selama et al. Determination of the polyphenolic content of Ammodaucus leucotrichus Cosson and Durieu by liquid chromatography coupled with mass spectrometry and evaluation of the antioxidant and antiglycation properties
Nair A simple protocol for the isolation of amentoflavone from two species of Biophytum DC.(Oxalidaceae) and evaluation of its antiproliferative potential
AU1363399A (en) Pharmaceutical grade ginkgo biloba
Siddiqui et al. Quantitative determination of alliin in dried garlic cloves and products by high-performance thin-layer chromatography
CA2307047A1 (fr) Ginseng de qualite pharmaceutique
WO1999021006A1 (fr) Valeriane, actee a grappes, vitex agnus-castus, airelle et chardon-marie de qualite pharmaceutique
Titus et al. Toxicological evaluation of aqueous stem bark extract of guiera senegalensis on wistar rats
Stremoukhov et al. Phytochemical research and anti-inflammatory activity of the dry extracts from northern highbush blueberry leaves
Gupta et al. CYTOTOXIC AND ANTI-INFLAMMATORY ACTIVITY OF AQUEOUS EXTRACT OF Strychnos nux-vomica
SRINIVASULU et al. Phytochemical and HPTLC studies on fruit extracts of Momordica cymbalaria Fenzl, a medicinally important plant
Olusegun et al. Hepatoprotective potential of Russelia equisetiformis plant extract on drug-induced hepatotoxicity in experimental models
AU1363199A (en) Pharmaceutical grade st. john's wort
Gbadegesin et al. Ethanol extract of Terminalia avicennioides root bark protects against cadmium toxicities in rats
Tu et al. Determining the effective compounds of Salvia miltiorrhiza through chromatographic fingerprinting coupled with chemometrics
Sudhakaran Finger Printing of the Anatomical Markers, HPTLC Profile and Heavy Metals Content in the Leaves of Aristolochia indica Linn.
Anokwuru Phytochemical, biological and toxicity studies of Terminalia sericea Burch.(Combretaceae)
Oyero et al. Immunomodulatory Potential of Herbal Formulations Containing Seeds of Nigella sativa Linn.
Shantakani Srinivasulu et al. Phytochemical and HPTLC studies on fruit extracts of Momordica cymbalaria Fenzl, a medicinally important plant.

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 20021023